Chemiluminescence of phagocytic cells caused by N-formylmethionyl peptides by Hatch, GE et al.
CHEMILUMINESCENCE  OF  PHAGOCYTIC  CELLS  CAUSED  BY 
N-FORMYLMETHIONYL  PEPTIDES* 
BY GARY E.  HATCH, DONALD E.  GARDNER, AND DANIEL B.  MENZEL 
(From the Department of  Pharmacology and Medicine, Duke University, Durham, North Carolina 
27706, and the Biomedical  Research Branch, Health Effects Research Laboratory, Environmental 
Protection Agency, Research  Triangle Park, North Carolina 27711) 
The microbicidal action of leukocytes is thought to proceed in part through 
oxygen-dependent reactions.  Molecular oxygen can be reduced to  superoxide 
radical anion (02-)  1 which, along with its products, may react directly with the 
micro-organism  (1,  2),  or  H2Os and  halide  may  act  as  substrates  for  the 
halogenation  of  bacteria  by  myeloperoxidase  (3,  4).  Both  superoxide  and 
myeloperoxidase-dependent reactions exhibit chemiluminescence in vitro and 
they appear to be major sources of light emitted from living cells that are in 
the  process  of phagocytizing foreign material  (5). Most  previous  studies  of 
chemiluminescence in leukocytes have employed particulates (zymosan, heat- 
killed bacteria, and polystyrene butadiene particles), which stimulate phagocy- 
tosis as well as O~ metabolism and in some cases appear to act as substrates in 
light producing reactions (5). Interest in the purely oxidative reactions as well as 
preliminary studies by Allred and Hill (5a) led us to the discovery that N-formyl- 
methionyl peptides  stimulate  chemiluminescence. These  unique  compounds, 
which are found in procaryotes, were recently shown to stimulate both chemo- 
taxis and lysosomal enzyme release in leukocytes (6, 7). 
In this paper we describe some of the properties of N-formylmethionyl (F- 
Met) peptide-induced chemiluminescence in human polymorphonuclear leuko- 
cytes (PMN) and in PMN and macrophages from guinea pigs and rabbits. 
Materials and Methods  2 
Reagents.  Zymosan, xanthine oxidase (grade I), xanthine, horse-radish peroxidase (type 1), 
superoxide dismutase  (bovine blood,  3,000 U/rag), F-Met-Phe, F-Met-Val, F-Met-Ala, Met-Phe, 
F-Met, and luminol were obtained from Sigma Chemical Co.,  St.  Louis,  Mo. SodiUm azide was 
obtained from Fisher Scientific Co.,  Pittsburg,  Pa.,  and cytechalasin B from Aldrich Chemical 
Co.,  Milwaukee, Wis.  F-Met-Leu-Phe was a  generous gii~ of Dr.  Elliott Schiffmann,  National 
Institutes of Health, Bethesda, Md. Zymosan suspensions were prepared by boiling a solution of 
* Supported by EPA Contract no.  68°02-2436. 
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Gey's balanced salt solution (GBSS, Microbiological Associates, Bethesda, Md.) containing 5 rag/ 
ml of zymosan. The boiled zymosan suspension was then centrifuged, resuspended in GBSS, and 
kept  frozen  until  use.  Superoxide  dismutase  was  dissolved in  saline  to  give a  stock  solution 
containing 5 mg/ml. 
Isolation of Human Leukocytes.  10  ml of heparinized  venous blood obtained  by vacutainer 
(Becton,  Dickinson  &  Co.,  Rutherford,  N.  J.,  heparin  sodium  14  U/ml)  from  two  human 
volunteers was sedimented for 1 h  after addition of dextran 70 (Abbott Laboratories,  Chemical 
Div., North Chicago, Ill.). The final concentration of dextran in the blood was 1%. The supernate 
containing the leukocytes and platolets was layered over lymphocyte separation medium (Bionetics 
Laboratory Products, Kensington, Md.) and was centrifuged at 400 g for 30 rain. Mononuclear cells 
were recovered from the plasma-lymphocyte separation  medium interface,  and  PMN from the 
bottom of the tube. Erythrocyte contamination of PMN was eliminated by resuspending the cells 
in 0.83%  NH4C1,  pH 7.2,  for 10  rain  at room temperature.  Cellular suspensions  were made  in 
GBSS. 
Preparation of Alveolar Macrophages  and Peritoneal Cells.  Male New Zealand white rabbits, 
1-2 kg (Pel-Freeze Biologicals, Inc., Rogers, Ark.) and Hartley strain guinea pigs, COBS (Cesarean 
obtained, barrier sustained) 650-800 g (Charles River Breeding Labs, Wilmington, Mass.) were used 
in these experiments. The technique of Coffin et ai. (8) was used to obtain alveolar macrophagee 
(AM). Animals were killed by cervical dislocation, the trachea was exposed, incised, and a catheter 
inserted. The lungs were then flushed five to six times with saline warmed to 37°C (30 ml for rab- 
bits and 10 ml for guinea pigs). Noninduced peritoneal macrophages (PM) were obtained by peri- 
centesis and lavage with warm saline.  Only cellular suspensions  containing greater than  98% 
mononuclear cells were used. Rabbit and guinea pig peritoneal PMN were prepared as described 
previously (7) by intraperitoneal injection of 60 or 20 ml of saline containing 0.1% glycogen (ICN 
Nutritional Biochemicals Div., International Chemical & Nuclear Corp., Cleveland, Ohio) 12-14 h 
before peritoneal lavage. 
Chemiluminescence Measurements.  Measurements of chemiluminescence were made with an 
ATP spectrophotometer  (model 3000 SAI Technology Co., San Diego, Calif.).  Light intensity in 
the reaction vial was monitored continuously by use of a  strip chart recorder (Fisher Recordall 
Series 500, Pittsburgh,  Pa.), and values of light intensity were recorded in volts. A wide range of 
sensitivity in  the  measurement  of light  could be  obtained  by changing  the sensitivity of the 
spectrophotometer or the sensitivity of the strip chart recorder. The temperature of the counting 
chamber  of the  spectrophotometer  was  31°C,  therefore,  vials containing  cells were  kept  in  a 
waterbath maintained at the same temperature.  New plastic scintillation vials (Fisher Scientific 
Co.)  were  used  throughout,  and  the  chemiluminescence  experiments  were  performed  in  a 
partially darkened room. Under these conditions, luminescence readings of the plastic vials were 
less  than 1.0 mV/viai 15 s after  placing them in the spectrophotometer. Samples for  chemilumi- 
nescence measurements were prepared by adding one part of  cellular  suspension to one part of 
1% bovine serum albumin (BSA) in GBSS to form a sample volume of  either  1 or 2 ml. Luminol 
solutions (0.2 raM) were prepared in 1%  BSA  (Pentex crystallized  bovine  albumin,  Miles 
Laboratories, Inc.,  Miles Research Products, Elkhart, Ind.)  in GBSS by stirring  at 4°C until 
dissolved  (6-8  h). The solution  was sterilized  by micropore filtration  and stored  in a dark bottle 
at  4°C.  Experiments in  which  the luminol  concentration  was varied were performed by making a 
0.2 M  solution  of luminol in dimethyl sulfoxide (Fisher  Scientific  Co.)  and then adding the 
dimethyl sulfoxide-luminol  solution  directly  to the samples at a dilution  of 1:1,000  or 1:2,000. 
Addition of  dimethyl sulfoxide  to cell  suspensions to final  concentrations  as  high as 0.5% had no 
effect  on subsequent F-Met-Phe-induced chemiluminescence. Dimethyl sulfoxide  was also  em- 
ployed to dissolve F-Met peptides  when their  final  concentrations in cells  were 0.5 mM  or 
greater. Solutions of  luminol in GBSS or GBSS plus BSA prepared by either of the methods 
described yielded very low levels  of  light  (<3.0 mV/ml). Numerical values for increases  in the 
chemiluminescence of  cells  were determined by subtracting  the basal light  intensity  (in volts) 
from the peak light  intensity  observed after  the addition  of  a stimulant. Most cell  preparations 
exhibited very low basal levels  of chemiluminescence (<30 mV/106 cells  with luminol present 
and <3.0 mV/5 × 10  e  cells  in  the absence of  luminol),  and these levels  remained low for  several 
hours. The activities  of the various peptides, determined by graphical approximation,  are 
reported as the ED50, the concentration giving 50% of  the maximal activity.  Other tests  on the 184  PEP'rIDE-INDUCED  CHEMILUMINESCENCE 
cells were usually performed at the concentration of F-Met peptide giving 80% of the maximal 
response (ED80). 
Results 
Characteristics of the Chemiluminescent Response to F-Met Peptides.  Chemi- 
luminescence induced by F-Met peptides was different from that produced by the 
commonly used particulate stimulant, zymosan, in that maximal levels of light 
intensity were reached sooner (Fig. 1). The major burst of  light occurred within 2 
rain after addition of F-Met-Phe while the maximum zymosan-induced chemi- 
luminescence occurred after 8 rain. F-Met peptides other than F-Met-Phe also 
exhibited a  similar time-course. After an initial burst of light, F-Met peptide- 
induced chemiluminescence appeared to decrease exponentially with a half-life 
of 1-2 min, but light emissions remained above basal levels for at least 15 min. 
A chemiluminescent response to F-Met-Phe was also observed with rabbit and 
guinea pig PMN as well as guinea pig AM and PM. The time-courses of  response 
in these cells were similar to that observed in the human PMN. 
Luminol Enhancement  of Chemiluminescence.  Luminol increased the  in- 
tensity of F-Met peptide and zymosan-induced chemiluminescence, while the 
time courses of these responses remained the same as they were in the absence 
of luminol.  Fig.  2  shows  that  the  addition  of 10 -7  M  luminol  resulted  in 
approximately a  10-fold enhancement of existing chemiluminescence. Increas- 
ing the luminol concentration to 10  -8 M also resulted in a 10-fold enhancement, 
but at concentrations of 10 -5  and 10  -4  M only a  5-fold enhancement over the 
previous lower concentration was seen. Higher concentrations of luminol were 
not possible  because of its  limited solubility.  Both F-Met-Phe  and zymosan- 
induced chemiluminescence appeared to be enhanced similarly by luminol..~ 
luminol concentration of 10  -4 M was arbitrarily chosen for the remainder of the 
experiments reported here because it was near the maximal enhancement of 
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FIG.  1.  Time-course of the chemiluminescent response of human PMN induced by I0 ~M 
F-Met-Phe and 0.5 mg/ml zymosan.  Each 2 ml test solution contained 5  x  10  ~ PMN and 
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FIG.  2.  The effect of luminol concentration on the chemiluminescent response of human 
PMN stimulated  by F-Met-Phe and zymosan.  Human  PMN  (5  x  10  ~ cells/2 ml sample) 
were  suspended  in  GBSS containing  0.5%  BSA.  The  concentrations  of F-Met-Phe  and 
zymosan were 1 ftM and 0.5%,  respectively. 
light  intensity  observed.  At  this  concentration,  luminol  increased  light 
output 3,000-6,000-fold  over that seen in its absence. 
Cell-Dependence of F-Met-Phe.Induced Chemiluminescence.  No light pro- 
duction was seen when 10 ~M F-Met-Phe was added to 10  -4 M luminol in 0.5% 
BSA  with no  cells present,  or  to  cells that were  disrupted by sonication or 
killed  by  heat-treatment  (100°C,  3  rain).  The  concentration of cells  in  the 
counting vials also affected the  luminescent response to F-Met-Phe  (Fig.  3). 
When the concentration of  cells  was increased from 0.I to I0 × 106 cells/ml,  the 
chemiluminescent  response to an ED80 dose of F-Met-Phe was also increased 
proportionately. In addition, cells  previously  exposed to F-Met-Phe  were less 
responsive  for at least 1 h to a second challenge of  the peptide. Larger initial 
doses gave greater deactivation. Previous addition of F-Met-Phe  also caused 
deactivation when cells  attached to glass vials were washed free  of  the initial 
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FIG.  3.  Dependence of F-Met-Phe-induced chemiluminescence on cell concentration, Each 
value represents the mean of three determinations.  Standard deviations are within the 
size  of each  point.  Each  2  ml  test  sample  contained the  given concentration of rabbit 
peritoneal PMN, 0.5% BSA, and 0.1 mM luminol. The ED80 concentration  of F-Met-Phe 
for these cells (2 ~M) was added to each vial, and the peak chemiluminescence  recorded. 
Effect of F-Met-Phe in Different  Cell Types.  Chemiluminescent responses 
in the presence of luminol were highly reproducible within a  given batch of 
cells  and  easily  measured  even  when  only  a  small  number  of  cells  was 
available. Different cell types were compared for their ability to respond to F- 
Met  peptides  in  the  presence  of luminol.  Table  I  shows  that  the  maximal 
chemfluminescent response  attainable  with  the  model  peptide,  F-Met-Phe, 
was  different in  different cell  types.  Human PMN  were  more  active by  an 
order of magnitude than other cells.  Guinea pig AM,  PM,  PMN,  and rabbit 
PMN had intermediate chemiluminescent activity. Rabbit AM did not appear 
to respond to the peptides although they did respond to unopsonized zymosan 
(366 mV/108 AM for 0.5 mg/ml zymosan). A small but measurable F-Met-Phe- 
induced chemiluminescent response  was  seen  in rabbit  PM,  however,  these 
cells  did not respond as  well as  the  AM to  unopsonized zymosan (6  mV/10  e 
cells).  The  human mononuclear cell fraction always contained at  least  10% 
PMN. Because of the high chemiluminescent activity of human PMN we were 
unable to determine whether the monocytes or lymphocytes of human blood G.  E.  HATCH,  D.  E.  GARDNER,  AND  D.  B.  MENZEL 
TABLE  I 
Maximal Chemiluminescent  Response to F-Met-Phe in Different 
Cell Types 
Maximal F-Met-Phe-induced 
Cell  type  chemiluminescence 
(V/10 e cells)* 
Human  PMN  120.0  ±  76.0  (5) 
Guinea pig AM  13.0  ±  2.9  (3) 
Guinea pig peritoneal PMN  7.2  ±  2.4  (5) 
Rabbit peritoneal PMN  7.9  ±  0.7  (3) 
Rabbit AM  0.001  ±  0.001  (3) 
Rabbit PM  0.002  ±  0.001  (4) 
* Each value represents the mean  _+  SD of the maximum  increase in 
chemiluminescence seen in a  dose-response curve to F-Met-Phe.  The 
number  of cell  preparations  is  in  parentheses.  All  measurements 
were  made on  1-ml samples, each of which contained  0.3-0.5  ×  10  e 
cells, 0.5% BSA, and 0.1 mM luminol. 
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can be stimulated by the F-Met peptides to give a chemiluminescent response. 
Structure  Activity  Relationships  of  Peptides  in  the  Chemiluminescent 
Assay.  The  dose-response  behavior  of F-Met  peptides  were  examined  in 
human PMN, in glycogen-induced  PMN and noninduced AM and PM of rabbits 
and guinea pigs.  A representative experiment in Fig.  4 shows that when the 
increase in chemiluminescence  was plotted against the logarithm of the molar 
concentration of peptide, a sigmoidal-shaped dose-response curve was obtained. 
As peptide concentrations were increased above those which produced a maxi- 
mal response, the chemiluminescence  was often decreased. Maximal chemilu- 
minescent responses in a  given batch of cells were the same for F-Met-Leu- 
Phe,  F-Met-Phe,  and F-Met-Val; however, F-Met-Ala consistently yielded a 
lower maximal response than the other peptides. No chemiluminescent  response 
could be detected al~er addition of millimolar concentrations of F-Met, Phe, or 
Met-Phe in  any of these  experiments. Table  II  presents data  from several 
experiments similar to  that  shown in  Fig.  4.  The relative potencies of the 
formylated peptides in inducing chemiluminescence was the same in all cell 
types examined, e.g., F-Met-Leu-Phe >> F-Met-Phe > F-Met-Val > F-Met-Ala. 
Similar  results  were  obtained  in  experiments  performed  without  luminol 
present. For example, ED50 values for the F-Met peptide induced chemilumi- 
nescence of guinea pig PMN in the absence of luminol were: F-Met-Leu-Phe, 
2.0 nM; F-Met-Phe, 0.45/~M;  F-Met-Val, 21.0 ftM; F-Met-Ala, 1.1 raM. These 
ED50  values  compare favorably with  experiments performed with  luminol 
present (Table II).  Some differences between cell types could be noted in the 
absolute potencies of the  peptides,  for example,  ED50  values for all  of the 
peptides, except F-Met-Ala, were about 10-fold higher in human PMN than in 
the other cell types. 
The Effect of Superoxide Dismutase on F.Met Peptide-Induced Chemilumi- 
nescence.  Fig. 5 shows that addition of low concentrations of SOD to suspen- 
sions of guinea pig PM and PMN resulted in a dose-related inhibition of F-Met- 
Phe-induced chemiluminescence. Complete  inhibition  of chemiluminescence 
was achieved by 10  /~g/ml of superoxide dismutase in these cells, in human 188  PEP'rIDE-INDUCED  CHEMILUMINESCENCE 
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FIG. 4.  The effect  of  poptide and amino acid  structure and concentration on ability  to 
induce  chemiluminescence in  rabbit  PMN. All  measurements were made on 1-ml samples 
containing 0.5 x 10  6  cells,  0.5% BSA, and 0.1  mM  luminol  in  GBSS. Effects  of  Met-Phe, /x; 
F-Met, •; Phe, 0; and formylated dipeptides  as labeled,  O; are represented. 
TABLE  H 
Comparison of ED50 Values of Four F-Met Peptides in Inducing Chemiluminescence in 
Different Cell Types* 
Cell  type  F-Met-Leu-Phe  F-Met-Phe  F-Met-Val  F-Met-Ala 
nM  ~  ~  mM 
Human PMN  63.0  ±  28.0  1.9  _~  0.17  16.0  -+ 3.1  2.6  ±  1.7 
Guinea pig PMN  5.3  ±  1.1  0.18  ±  0.02  2.5  _+ 0.6  1.3  _+  0.2 
Guinea pig AM  6.0  __,  2.8  0,20  _+  0.007  3.5  ±  0.7  2.0  _+  1.2 
Guinea pig PM  8.7  ±  2.1  0.20  ±  0.006  5.0  +-  1.2  5.5  ±  2.4 
Rabbit PMN  0.95  ±  0.3  0.64  _+  0,2  16.0  -+ 4.0  5.9  ±  3.9 
* Concentrations of the F-Met peptides which produced a  1/2 maximal chemiluminescent response 
(ED50) are shown. Each concentration value represents the mean _+ SD of the ED50 calculated 
from three separate cell preparations. All measurements were made on 1-ml samples containing 
0.3-0.5  x  106 cells, 0.1 mM luminol, and 0.5% BSA in GBSS. 
PMN, and in PM and AM from guinea pigs. The luminol-enhanced chemilumi- 
nescent response was also completely inhibited by this concentration of SOD. 
The Effect of Cytochalasin B  and Azide on F-Met Peptide-Induced Chemilu- 
minescence.  The  role  of lysosomal  enzyme  release  in  F-Met-Phe-induced 
chemiluminescence was examined in  guinea pig  PMN  and PM  (Table III). 25 
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Fro. 5.  Inhibition  of  the F-Met-Phe-induced  chemiluminescent  response by SOD. Each 1 
ml sample contained 5 × 10  ~  cells,  0.5% BSA in GBSS, and the ED80 concentration of  F- 
Met-Phe for  that  batch  of  cells.  Inhibition  by SOD is  shown for  guinea  pig  peritoneal  PMN 
(@) and guinea pig PM (©).  Mean values are plotted  (n = 1-3 per point). 
TABLE  HI 
The Effect of Cytochalasin B  and Azide on F-Met-Phe-Induced 
Chemiluminescence* 
Increase in chemiluminescence 
(percent  of  control  ± SE) 
Peritoneal  macro-  Polymorphonuclear 
phage  leukocyte 
ED80 Dose of  F-Met-Phe  100% 
(control) 
" + 1 /~M Cytochalasin B  81.6 ± 4.40% 
" + 0.1 mM  NaNs  89.4 ± 10.9% 
" 1 ~M Cytochalasin B +  78.9 ± 6.5% 
0.1 mM  NaN3 
100% 
336  -  109% 
69.5 ± 5.68% 
83.7  ±  7.34% 
* All measurements were made on l-ml samples containing 0.3-0.5 x  10  e 
guinea pig  cells,  0.1  mM  luminol, and 0.5% BSA in  GBSS. Each percentage 
value  was  calculated  from  the increases  in  chemiluminescence seen  in  three 
to four  cell  preparations from different  animals. The ED80 concentration of 
F-Met-Phe was approximated graphically for each cell  preparation before 
the experiment. All experiments were performed by preincubating cells  for 
5 rain  with NaN3 and/or cytochalasin  B before  addition  of  F-Met-Phe. 190  PEPTIDE-INDUCED  CHEMILUMINESCENCE 
Cytochalasin B,  which causes extracellular release of lysosomal enzymes in 
cells stimulated by the F-Met peptides (7) caused a  threefold enhancement of 
chemiluminescence in PMN,  and a  small inhibition of chemiluminescence in 
PM (Table III). The enhancement of F-Met-Phe-induced chemiluminescence  by 
cytochalasin B was completely  abolished by addition of the peroxidase inhibitor, 
sodium azide.  Azide (0.1 mM) by itself did not appear to have a  significant 
effect in macrophages, while it generally inhibited to some degree the response 
in PMN. In other experiments, human PMN also showed an enhanced chemi- 
luminescent response to  1  ~M  cytochalasin B  (275% over control) that  was 
inhibitable by azide.  Guinea pig AM gave results similar to those seen with 
the PM. Therefore, F-Met-Phe-induced chemiluminescence  in PMN showed an 
azide-inhibitable enhancement in the presence of cytochalasin B, while macro- 
phages showed no enhancement. This effect was seen both in the presence and 
absence of luminol. 
Discussion 
PMN isolated from human blood, as well as PMN and macrophages obtained 
from  guinea  pigs  and  rabbits  chemiluminesce when  stimulated  by  certain 
N-formylmethionyl  peptides. These peptides, which are believed to be present 
in  bacteria  but  not  mammalian cells,  have  been  shown  previously to  be 
recognized at low concentrations by phagocytes. They are capable of initiating 
both the secretion of lysosomal enzymes and directed cell migration (9,  10). 
Results  presented here suggest that  yet another cellular activity might be 
initiated by these peptides, e.g., the production of highly reactive molecules of 
possible importance in microbial killing. 
The cellular nature of F-Met-Phe-induced chemiluminescence  was indicated 
by its dependence on cell concentration, and its inhibition by cell disruption, 
heat inactivation, or previous maximal stimulation of the cell by the peptide. 
Luminol,  a  chemiluminescent indicator of oxidizing species,  enhanced in  a 
dose-related manner the intensity of the chemiluminescent response caused by 
both zymosan and F-Met-Phe (Fig. 2). No difference was seen between the time 
courses of the luminol-enhanced and the luminol-independent chemilumines- 
cent  responses.  This  effect was  in  agreement with  previous  studies  with 
zymosan (11). The use ofluminol to enhance chemiluminescence  made the study 
of the  effects  of the  peptides  more  facile  in  both  PMN  and  noninduced 
macrophages. 
Comparison of different cell types in their ability to respond to F-Met-Phe in 
the presence of luminol showed marked differences between species (Table I). 
The maximal chemiluminescence  attainable in a dose-response curve to F-Met- 
Phe ranged from near zero in rabbit macrophages to very high levels (120 V/106 
cells)  in  human  PMN.  Glycogen-induced rabbit  and  guinea  pig  peritoneal 
PMN gave chemiluminescent responses of intermediate intensity, as did non- 
induced macrophages of the guinea pig. Rabbit AM gave no chemiluminescent 
response  to  the  peptides,  while  they  did  respond  to  zymosan,  suggesting 
perhaps that these cells lack the receptor for F-Met peptides. 
Dose-response studies with different F-Met peptides showed that molecular 
structure  had  large  effects on  the  potency of the  peptides  in  stimulating G.  E.  HATCH,  D.  E.  GARDNER,  AND  D.  B.  MENZEL  191 
chemiluminescence.  For example, Met-Phe, F-Met, and Phe had no measurable 
activity even at millimolar concentrations, while F-Met-Phe was active in the 
micromolar range (Fig. 5). The same relative potency was seen for the peptides 
whether human, rabbit,  or guinea pig PMN or guinea pig AM or PM were 
tested (Table I). Relative potencies of the four active peptides, as indicated by 
their ED50 values was in all cases F-Met-Leu-Phe >> F-Met-Phe >  F-Met-Val 
>  F-Met-Ala. This relationship was seen both in the presence and absence of 
luminol. Average ED50 values of the peptides in inducing chemiluminescence 
(Table II) are similar to EDS0 values of the peptides reported previously for the 
induction of chemotaxis and lysesomal enzyme release. For example, Showell 
et al.  (7) reported the EDS0 values of F-Met-Leu-Phe and F-Met-Phe as 0.24 
nM and 1.5 ~M, respectively, for the induction of lysosomal enzyme release in 
rabbit PMN. Average ED50 values for the induction of chemiluminescence in 
the same type of cells (Table II) were 0.95 nM and 0.64 ~M. Relative activities 
of F-Met-Phe, F-Met-Val, and F-Met-Ala reported previously by Schiffmann et 
al.  (6) in inducing chemotaxis in rabbit PMN also appear to be similar to the 
relative activities of these peptides in inducing chemiluminescence. The only 
discrepancies that may exist are that the earlier studies reported chemotactic 
and lysosomal enzyme releasing activity for high concentrations (1-10 raM) of 
F-Met, while we were unable to see a chemiluminescent  response to this agent. 
Also,  dose-response curves of the peptides in  inducing the former responses 
showed the same maxima for all peptides, while dose-response curves in the 
chemiluminescent response had an exception, e.g. F-Met-Ala always produced 
a lower maximal response than the other peptides. The reason for this effect is 
not yet apparent. 
Further investigations were directed at  understanding the  nature  of the 
chemiluminescent molecules produced by the cells in response to  the F-Met 
peptides. Inhibition of the F-Met peptide-induced chemiluminescent response 
by SOD  (Fig.  5) suggests the involvement of O2- or O2--derived compounds. 
SOD inhibition was complete in all cells examined (no luminol present) when a 
concentration of 10 ~g/ml was used. Using a variety of other cellular stimulants, 
previous investigators have also observed an inhibition of chemiluminescence 
by  SOD  (9,  10). Beall  et  al.  (12) showed  recently  that  human  alveolar 
macrophages gave a chemiluminescent response to heat-killed bacteria and to 
phorbol myristate acetate that was completely inhibited by 100  ~g/ml SOD. 
Zymosan-induced chemiluminescence in  human  PMN,  however,  was  only 
partially (55%) inhibited by SOD (94 ~g/ml) in studies by Rosen and Klebanoff 
(5).  They  suggest  that  the  zymosan-induced chemiluminescence in  human 
PMN is due to both azide-inhibitable peroxidases and O2--dependent reactions. 
Since our studies show complete inhibition of F-Met peptide-induced chemilu- 
minescence by  SOD  in  all  cells  examined including  human  PMN,  F-Met 
peptides and zymosan may differ in their ability to release lysosomal myelo- 
peroxidase. Differences may also exist in the nature of the oxidizable substrates 
which participate in the chemiluminescent reactions. Zymosan was shown by 
Rosen  and  Klebanoff to  be  a  substrate  in  chemiluminescent reactions  of 
myeloperoxidase and  xanthine  oxidase.  It  seems  unlikely  that  the  F-Met 
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concentrations.  Also, repeated additions of the peptides do not lead to repeated 
enhancement of light production, as might be expected if they were substrates. 
The  small  amount  or  lack  of  inhibition  by  azide  of  F-Met-Phe-induced 
chemiluminescence  suggested  that  myeloperoxidase  reactions  are  not  major 
sources of light  under the conditions used in these experiments.  Since myelo- 
peroxidase  is present  in the dense granules  of PMN  (13),  its release into the 
medium  surrounding  the  cells  might  be  an  expected  prerequisite  for  its 
involvement in a chemiluminescent response. Support of this idea was found in 
the effects of cytochalasin B. Cytochalasin B, which is known to cause external 
release of lysosomal enzymes in PMN stimulated with F-Met peptides (7),  also 
enhanced F-Met-Phe-induced chemiluminescence in PMN. Macrophages,  how- 
ever,  showed no  such  enhancement,  in  agreement  with  the  reported  lack of 
granule-associated myeloperoxidase in these cells (14,  15). The enhancement of 
chemiluminescence  caused by cytochalasin B  was inhibited by the peroxidase 
inhibitor,  sodium  azide,  also  supporting  the  conclusion  that  the  increased 
chemiluminescence was due to myeloperoxidase release. 
All  of  the  experiments  reported  here  could  be  performed  either  in  the 
presence or absence of luminol with similar results.  Luminol  made possible a 
greater  number  of experiments  in  a  given batch  of cells.  Unfortunately,  the 
chemical nature of both native and luminol-enhanced chemiluminescence have 
not been worked out in enough detail to provide an adequate comparison of the 
two.  Our  experiments  suggest  that  luminol  scavenges  the  same  oxidizing 
species as causes native chemiluminescence.  Both O2--forming (e.g., xanthine 
-xanthine  oxidase) and peroxidase-catalyzed reactions yield native chemilumi- 
nescence  (5,  16,  17) and oxidize luminol  (18,  19). Both types of reaction  have 
counterparts in leukocyte metabolism.  Metal ions also catalyze luminol oxida- 
tion, but only in alkaline solutions (18, 20). Inhibition of luminol chemilumines- 
cence by SOD apparently does not prove that O2- is responsible for its oxidation. 
Hodgson and Fridovich (18) have suggested that  02- is formed during aerobic 
luminol oxidation initiated by oxidants other than 02-. Therefore, SOD appears 
to inhibit  luminol luminescence regardless of the nature of the oxidant which 
initiates its oxidation (21). Zymosan appears to be a substrate in chemilumines- 
cent  reactions  of leukocytes,  therefore  it  is  possible  that  luminol  is  also  a 
substrate for oxidizing chemiluminescent reactions.  The use of model cellular 
stimulants as well as model substrates may provide new avenues for elucidating 
the microbicidal mechanisms of phagocytic cells. 
The observed similarities in the structure-activity relationships for chemilu- 
minescence,  lysosomal enzyme release,  and chemotaxis raises the question of 
whether  one  of the  processes is  a  direct  result  of the  other.  For example,  if 
chemiluminescent  substances were released with lysosomal enzymes it would 
account  for the  similar  structure-activity  relationships  of the  two processes. 
Recent reports indicate,  however, that O2- and H202 are not released with the 
lysosomal enzymes (22, 23) and therefore it would be expected that chemilumi- 
nescence caused by direct reactions of these agents would occur independently 
of enzyme release. Another explanation might be that the granule-associated 
myeloperoxidase reacts with H202 extracellularly or in the phagocytic vacuoles, 
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peptide-induced chemiluminescence.  This seems unlikely because sodium azide, 
an inhibiter of myeloperoxidase, had little inhibitory effect on chemilumines- 
cence caused by F-Met peptides unless lysosomal enzyme release was enhanced 
by  cytochalasin B.  Also,  macrophages did  not  exhibit  an  azide-inhibitable 
chemiluminescent response even when cytochalasin B was present, indicating 
that  peroxidases are  not  involved in  the  chemiluminescence of these  cells. 
Thus, it seems likely that the F-Met peptides trigger the O2--forming machinery 
of the cell in addition to activating lysosomal enzyme secretion. If this is so, 
the apparent similarities in the structure-activity relationships of F-Met pep- 
tide-induced chemiluminescence, chemotaxis and  lysosomal enzyme release 
would indicate that these processes result from activation of a single receptor 
mechanism. 
Summary 
N-formylmethionyl (F-Met) peptides, when added alone to macrophages or 
polymorphonuclear leukocytes (PMN), were found to induce a  chemilumines- 
cent response of shorter duration than that produced by the commonly  employed 
particulate stimulant, zymosan. The cellular nature of F-Met peptide-induced 
chemiluminescence  was indicated by its dependence on cell concentration, and 
by its  inhibition by cell disruption,  heat inactivation,  or previous maximal 
stimulation by the peptides. 
Comparison of PMN and macrophages from different species showed that the 
maximal chemiluminescent  response seen in the dose-response curve of F-Met- 
Phe was different in different cell types. Chemiluminescence reached highest 
values in human PMN,  it was intermediate in guinea pig macrophages and 
PMN,  and in rabbit PMN; but it was nonexistent in rabbit alveolar macro- 
phages and very low in rabbit peritoneal macrophages. A definite relationship 
was observed between peptide structure and chemiluminescent activity. Met- 
Phe, F-Met and Phe were inactive even at millimolar concentrations, while F- 
Met-Phe caused chemiluminescence  at micromolar concentrations. Four active 
peptides were tested in guinea pig, rabbit, and human PMN, and in guinea pig 
alveolar and peritoneal macrophages. The relative activity of these peptides 
was the same in all cells studied, e.g. F-Met-Leu-Phe >>  F-Met-Phe >  F-Met- 
Val >  F-Met-Ala. The values of ED50 for each peptide were also comparable to 
previously  reported  ED50  values  of these  peptides  in  inducing  lysosomal 
enzyme release. These results were seen both in the presence and absence of 
the chemiluminescent oxidant indicator, luminol. 
Low concentrations of superoxide dismutase (10 ~g/ml) completely inhibited 
chemiluminescence  caused by the F-Met peptides, suggesting the involvement 
of 02- or O2--derived compounds in this response. Sodium azide, an inhibitor of 
peroxidase  reactions,  had  either  no  effect or  a  slight  inhibitory  effect on 
chemiluminescence. However,  when  the  extracellular release  of lysosomal 
enzymes was induced by cytochalasin B, an azide-inhibitable enhancement of 
chemiluminescence was  seen  in  PMN,  but  not  in  macrophages.  This  effect 
appears to be correlated with the presence of granule-associated myeloperoxi- 
dase.  Although azide-inhibitable peroxidases could be  a  potential  source of 
light, they did not appear to be a significant contributor in these experiments. 194  PEP*rIDE-INDUCED  CHEMILUMINESCENCE 
Based on these results and on those of previous investigators, we postulate 
that the F-Met-peptides stimulate 02- production in addition to stimulating 
lysosomal enzyme release and chemotaxis. The similar structure-activity rela- 
tionship which appears to exist for these processes may indicate that they are 
all initiated by a single receptor mechanism. Since F-Met peptides are formed 
in bacteria it is likely that their actions represent an important physiologic 
response. 
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